Hypoxia-specific upregulation of the endogenous human VEGF-A gene by hypoxia-driven expression of artificial transcription factor

Tomoaki Mori, Jun Sasaki, Takuya Kanamori, Yasuhiro Aoyama, Takashi Sera

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Activation of vascular endothelial growth factor A (VEGF-A) is an attractive approach to treatment of ischemic diseases. Although zinc-finger-based artificial transcription factors (ATFs) were constructed for human VEGF-A and constitutive expression of ATFs upregulated the endogenous VEGF-A gene expression, activation of VEGF-A specifically in ischemic tissues is desirable for therapeutic application of ATF technology. Here, we describe hypoxia-specific activation of human VEGF-A gene by hypoxia-driven expression of the ATF. We constructed a hypoxia-driven promoter for the ATF expression and placed it upstream of the ATF-encoding regions. The resulting hypoxia-driven expression plasmid induced the ATF expression in hypoxia but not in normoxia, and the hypoxia-specific expression of the ATF activated the VEGF-A expression specifically in hypoxia. Thus, the engineered expression system of ATFs may enable activation of VEGF-A expression specifically in ischemic tissues without affecting normal, healthy tissues in vivo.

Original languageEnglish
Pages (from-to)845-848
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume390
Issue number3
DOIs
Publication statusPublished - Dec 18 2009
Externally publishedYes

Fingerprint

Transcription Factors
Up-Regulation
Genes
Vascular Endothelial Growth Factor A
Chemical activation
Tissue
Hypoxia
human VEGFA protein
Zinc Fingers
Gene expression
Transcriptional Activation
Zinc
Plasmids
Technology
Gene Expression

Keywords

  • Artificial transcription factor
  • Hypoxia
  • Hypoxia-response element
  • Ischemic diseases
  • Vascular endothelial growth factor A
  • Zinc-finger protein

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Hypoxia-specific upregulation of the endogenous human VEGF-A gene by hypoxia-driven expression of artificial transcription factor. / Mori, Tomoaki; Sasaki, Jun; Kanamori, Takuya; Aoyama, Yasuhiro; Sera, Takashi.

In: Biochemical and Biophysical Research Communications, Vol. 390, No. 3, 18.12.2009, p. 845-848.

Research output: Contribution to journalArticle

@article{e174cdc2e5ab465f8616d9cccc2566fb,
title = "Hypoxia-specific upregulation of the endogenous human VEGF-A gene by hypoxia-driven expression of artificial transcription factor",
abstract = "Activation of vascular endothelial growth factor A (VEGF-A) is an attractive approach to treatment of ischemic diseases. Although zinc-finger-based artificial transcription factors (ATFs) were constructed for human VEGF-A and constitutive expression of ATFs upregulated the endogenous VEGF-A gene expression, activation of VEGF-A specifically in ischemic tissues is desirable for therapeutic application of ATF technology. Here, we describe hypoxia-specific activation of human VEGF-A gene by hypoxia-driven expression of the ATF. We constructed a hypoxia-driven promoter for the ATF expression and placed it upstream of the ATF-encoding regions. The resulting hypoxia-driven expression plasmid induced the ATF expression in hypoxia but not in normoxia, and the hypoxia-specific expression of the ATF activated the VEGF-A expression specifically in hypoxia. Thus, the engineered expression system of ATFs may enable activation of VEGF-A expression specifically in ischemic tissues without affecting normal, healthy tissues in vivo.",
keywords = "Artificial transcription factor, Hypoxia, Hypoxia-response element, Ischemic diseases, Vascular endothelial growth factor A, Zinc-finger protein",
author = "Tomoaki Mori and Jun Sasaki and Takuya Kanamori and Yasuhiro Aoyama and Takashi Sera",
year = "2009",
month = "12",
day = "18",
doi = "10.1016/j.bbrc.2009.10.060",
language = "English",
volume = "390",
pages = "845--848",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Hypoxia-specific upregulation of the endogenous human VEGF-A gene by hypoxia-driven expression of artificial transcription factor

AU - Mori, Tomoaki

AU - Sasaki, Jun

AU - Kanamori, Takuya

AU - Aoyama, Yasuhiro

AU - Sera, Takashi

PY - 2009/12/18

Y1 - 2009/12/18

N2 - Activation of vascular endothelial growth factor A (VEGF-A) is an attractive approach to treatment of ischemic diseases. Although zinc-finger-based artificial transcription factors (ATFs) were constructed for human VEGF-A and constitutive expression of ATFs upregulated the endogenous VEGF-A gene expression, activation of VEGF-A specifically in ischemic tissues is desirable for therapeutic application of ATF technology. Here, we describe hypoxia-specific activation of human VEGF-A gene by hypoxia-driven expression of the ATF. We constructed a hypoxia-driven promoter for the ATF expression and placed it upstream of the ATF-encoding regions. The resulting hypoxia-driven expression plasmid induced the ATF expression in hypoxia but not in normoxia, and the hypoxia-specific expression of the ATF activated the VEGF-A expression specifically in hypoxia. Thus, the engineered expression system of ATFs may enable activation of VEGF-A expression specifically in ischemic tissues without affecting normal, healthy tissues in vivo.

AB - Activation of vascular endothelial growth factor A (VEGF-A) is an attractive approach to treatment of ischemic diseases. Although zinc-finger-based artificial transcription factors (ATFs) were constructed for human VEGF-A and constitutive expression of ATFs upregulated the endogenous VEGF-A gene expression, activation of VEGF-A specifically in ischemic tissues is desirable for therapeutic application of ATF technology. Here, we describe hypoxia-specific activation of human VEGF-A gene by hypoxia-driven expression of the ATF. We constructed a hypoxia-driven promoter for the ATF expression and placed it upstream of the ATF-encoding regions. The resulting hypoxia-driven expression plasmid induced the ATF expression in hypoxia but not in normoxia, and the hypoxia-specific expression of the ATF activated the VEGF-A expression specifically in hypoxia. Thus, the engineered expression system of ATFs may enable activation of VEGF-A expression specifically in ischemic tissues without affecting normal, healthy tissues in vivo.

KW - Artificial transcription factor

KW - Hypoxia

KW - Hypoxia-response element

KW - Ischemic diseases

KW - Vascular endothelial growth factor A

KW - Zinc-finger protein

UR - http://www.scopus.com/inward/record.url?scp=70449705832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449705832&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2009.10.060

DO - 10.1016/j.bbrc.2009.10.060

M3 - Article

C2 - 19836352

AN - SCOPUS:70449705832

VL - 390

SP - 845

EP - 848

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -